Patients with Pulmonary Metastases from Head and Neck Cancer Benefit from Pulmonary Metastasectomy, A Systematic Review

<i>Background and Objectives</i>: The incidence of distant metastases in patients with head and neck cancer (HNC) is approximately 10%. Pulmonary metastases are the most frequent distant location, with an incidence of 70–85%. The standard treatment options are chemo-, immuno- and radioth...

Full description

Bibliographic Details

Published in:	Medicina
Main Authors:	Georg Schlachtenberger, Fabian Doerr, Hruy Menghesha, Patrick Lauinger, Philipp Wolber, Anton Sabashnikov, Aron-Frederik Popov, Sascha Macherey-Meyer, Gerardus Bennink, Jens P. Klussmann, Thorsten Wahlers, Khosro Hekmat, Mathias B. Heldwein
Format:	Article
Language:	English
Published:	MDPI AG 2022-07-01
Subjects:	pulmonary metastasectomy lung metastases immunotherapy head and neck cancer metastatic head and neck cancer
Online Access:	https://www.mdpi.com/1648-9144/58/8/1000